desmopressin acetate · DESMOPRESSIN ACETATE 1.5 mg/mL · Spray · Nasal · Ferring Pharmaceuticals Inc.
NDC 55566-3000-00 · 2.5 mL in 1 BOTTLE, SPRAY · NDA · View full market →
Just 2 companies supply this market — thin enough that a single exit would be felt immediately. It is in shortage right now — FDA lists the reason as “delay in shipping of the drug”.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Not scored — fragility is computed for NADAC-priced NDCs.
OAI inspection at a producing facility (24 months) · price up 13% YoY · sole-source market
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
No enforcement reports list this package NDC.
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Apotex Corp. | DESMOPRESSIN ACETATE 10 ug/1 | Jul 15, 2026 | Sep 2, 2026 |
| Ferring Pharmaceuticals Inc. | DESMOPRESSIN ACETATE 1.5 mg/mL | Jul 24, 2026 | Aug 28, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
DrugDashboards, "Stimate — NDC 55566-3000-00," retrieved September 3, 2026, https://drugdashboards.com/drug/55566300000.
Free to cite with attribution — see how the data is put together.